• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Authors » Mike Ingram

Mike Ingram

Articles

ARTICLES

Patient-Driven Text

PRO Development Needs to Be Patient-Driven, New Guidelines Say

July 1, 2022
Mike Ingram
The best tools for capturing patient-reported outcomes (PRO) are ones patients helped develop, according to recently published guidelines on PRO best practices that point to increased accessibility, decreased patient burden and improved data consistency as major benefits. Read More
Decentralized Trial

The Risks and Rewards of Remote Technologies and Decentralized Trial Approaches

May 31, 2022
Mike Ingram
The increasing adoption of decentralized trial methods has brought with it a number of benefits, most of which outweigh the challenges remote operations present. But data management hurdles, technology limitations and the possibility of over-burdening study participants with self-managed tasks all need to be overcome to make decentralization successful. Read More
Leverage-360x240.png

Sites Have Leverage Over Intellectual Property Provisions in CTAs

January 17, 2022
Mike Ingram
When negotiating a clinical trial agreement (CTA), some of the most important provisions — and the most contentious — are those dealing with study data and intellectual property. Sponsors will want to own all the data, as well as any future inventions derived from it, but there are good reasons for sites to push back and insist on some exceptions. Read More
Compensation-Businessman-360x240.png

A PI Compensation Case Study: Stamford Health

November 8, 2021
Mike Ingram
This is the last installment of a four-part CenterWatch Weekly series on the principles and best practices of setting investigator compensation levels that are both fair and compliant with federal laws. In this article, we look at how a large healthcare network built a hybrid compensation model using various methodologies. Read More
Compensation-360x240.png

Combine Compensation Models for More Precise Investigator Payments

November 1, 2021
Mike Ingram
This is the third installment in a four-part CenterWatch Weekly series on the principles and best practices of setting investigator compensation levels that are both fair and compliant with federal laws. This week, we look at how methodologies for determining compensation can be combined and customized. Links to previous installments of the series are at the end of the article. Read More
Compensation-Businessman-360x240.png

Methods for Calculating PI Compensation: Pros and Cons

October 25, 2021
Mike Ingram
This is the second in a four-part CenterWatch Weekly series on the principles and best practices of setting investigator compensation levels that are both fair and compliant with federal laws. This week, we look at various methodologies for determining compensation. Read More
Compensation-360x240.png

Compensating Investigators: Core Principles of Compensation and Contracting

October 18, 2021
Mike Ingram
This is the first in a four-part CenterWatch Weekly series on the principles and best practices of setting investigator compensation levels that are both fair and compliant with federal laws. Read More
Balance scale

Balancing Personal Data Privacy and Research Data Transparency Brings Challenges

September 8, 2021
Mike Ingram
Much of the conversation about research data these days centers on how important it is to protect sensitive patient information, particularly as technology makes data-sharing easier at the same time regulatory agencies are requiring sponsors and researchers to share the results of their trials. Read More
Quality scale

Quality Measurement Tools, Tactics and Metrics for Site Staff

July 30, 2021
Elizabeth Tilley Hinkle and Mike Ingram
Quality metrics and their role as part of an overall quality management system (QMS) are an important component of clinical research, but not all sites use quality performance tracking tools to their maximum advantage: tracking quality performance and identifying areas for improvement. Academic and institutional researchers haven’t fully embraced the concept of taking methodical steps to examine operations across individual studies. Read More
Master Protocol

Master Protocol Trials Show Promise, but Operational and Cost Challenges Remain

March 31, 2021
Mike Ingram
The coronavirus pandemic has highlighted the effectiveness of large, multisite clinical trials run under master protocols, especially when it comes to evaluating multiple experimental treatment options simultaneously. Despite their advantages, there are some challenges and costs associated with running master protocol trials that the industry is still grappling with. Read More
View All Articles by Mike Ingram

Upcoming Events

  • 15Sep

    Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

  • 16Oct

    WCG MAGI's Clinical Research Conference 2022 West

  • 16Nov

    17th Annual FDA Inspections Summit

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Options-360x240.png

    Cancer Patients Signal Interest in Less Travel, More Remote Trial Options

  • SurveywBlueBackground-360x240.png

    New Study Shows Trends in Funding, Racial Balance Amidst COVID-19

  • Complexity-360x240.png

    Rising Trial Complexities Create More Payment Problems, Frustrations for Sites

  • Challenge-360x240.png

    BYOD Trials Growing in Popularity, But Unique Tech Challenges Remain

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing